Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data

Ann Neurol. 2011 Nov;70(5):857-61. doi: 10.1002/ana.22608.

Abstract

Amyloid-beta (Aβ) accumulation was evaluated with 2 [(11)C]Pittsburgh compound B (PiB) positron emission tomography scans about 2.5 years apart in 146 cognitively normal adults. Seventeen of 21 participants with initially elevated Aβ deposition demonstrated subsequent Aβ plaque growth (approximately 8.0% per year), and none reverted to a state of no Aβ deposits. Ten individuals converted from negative to positive PiB status, based on a threshold of the mean cortical binding potential, representing a conversion rate of 3.1% per year. Individuals with an ε4 allele of apolipoprotein E demonstrated increased incidence of conversion (7.0% per year). Our findings suggest that the major growth in Aβ burden occurs during a preclinical stage of Alzheimer disease (AD), prior to the onset of AD-related symptoms.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / psychology*
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / physiopathology
  • Aniline Compounds
  • Benzothiazoles
  • Brain / diagnostic imaging
  • Brain / physiopathology*
  • Carbon Radioisotopes
  • Cognition*
  • Early Diagnosis
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Plaque, Amyloid / diagnostic imaging
  • Plaque, Amyloid / physiopathology*
  • Positron-Emission Tomography* / methods
  • Thiazoles

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Aniline Compounds
  • Benzothiazoles
  • Carbon Radioisotopes
  • Thiazoles